Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • SEPTEMBER 2021 Issue has been successfully launched on 1 September 2021.



M. Narmatha* and N. Anu Prasad


Acute respiratory distress syndrome is a inflammatory conditions of the lung which is caused by direct or indirect lung injury includes pneumonia, sepsis, severe trauma and so on. It is also caused due to environmental and genetic factors. The pathology is identified by three phases such as exudative, proliferative and fibrotic phases. Destabilization of vascular endothelial cadherin due to the increased concentration of cytokines causes endothelial permeability. Epithelial injury is caused due to migration of neutrophils. The immune system which triggers the formation of cytokines, leukocyte proteases, and more also worsens the lung injury. The person who suffered from acute respiratory distress syndrome has the symptoms of severe hypoxia, tachycardia, difficulty in breathing, abnormally rapid breathing. Acute Respiratory Distress Syndrome is diagnosed by physical examination, patient history and Imaging techniques. Computed tomography is a golden standard techniques for measuring positive end expiratory airway pressure and tidal volume done in intensive care unit patients. Acute respiratory distress syndrome is treated with mechanical ventilation, fluid management and prone positioning. Drugs are used to reduce the inflammation and pulmonary oedema. Potent vasodilator are used to decreases the artery pressure. Vitamin C and D supplement is also recommended.

Keywords: Acute Respiratory Distress Syndrome (ARDS), Vascular Endothelial Cadherin (VE-Cadherin), diffuse alveolar damage, MSC therapy.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More